- Production of Human Fab Monoclonal Antibody to Surface Protein, preS1, of Hepatitis B Virus using Antibody Phage Display Library
-
Kim HS, Choi IH, Kim IJ, Chung JH, Park SK
- KMID: 1548380
- Korean J Immunol.
- 1997 Dec;19(4):549-558.
Human monoclonal antibodies have considerable potential in the prophylaxis and treatment of viral disease. By cloning human Ig gene segments from the B cells of volunteer into pComb3 phagemid vector,... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Diffuse Alveolar Hemorrhage Following Abciximab Therapy
-
Ryu HJ, Jung YS, Kim MH, Jung HJ, Jung BC, Lee BR, Kang HJ
- KMID: 2082464
- Korean J Med.
- 2013 Apr;84(4):562-566.
Platelets play an important role in the development of acute coronary syndrome. Platelet-inhibiting drugs, such as glycoprotein IIb/IIIa inhibitors, can be beneficial when they are administered at the time of... -
- CITED
-
- Close
- SHARE
-
- Close
- Acute Profound Thrombocytopenia after Using Abciximab for No-Reflow during Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
-
Park S, Lee J, Lee SY, Bae JW, Hwang KK, Kim DW, Cho MC, Kim SM
- KMID: 2224846
- Korean Circ J.
- 2013 Aug;43(8):557-560.
- doi: 10.4070/kcj.2013.43.8.557
Glycoprotein IIb/IIIa antagonists are well established for their effectiveness in improving clinical outcomes in acute coronary syndrome patients undergoing percutaneous coronary intervention. Acute profound thrombocytopenia is a rare complication of... -
- CITED
-
- Close
- SHARE
-
- Close
- Antibody to FcεRIα Suppresses Immunoglobulin E Binding to High-Affinity Receptor I in Allergic Inflammation
-
Hong JY, Bae JH, Lee KE, Kim M, Kim MH, Kang HJ, Park EH, Yoo KS, Jeong SK, Kim KW, Kim KE, Sohn MH
- KMID: 2427159
- Yonsei Med J.
- 2016 Nov;57(6):1412-1419.
- doi: 10.3349/ymj.2016.57.6.1412
PURPOSE: High-affinity receptor I (FcεRI) on mast cells and basophils plays a key role in the immunoglobulin E (IgE)-mediated type I hypersensitivity mediated by allergen cross-linking of the specific IgE-FcεRI... -
- CITED
-
- Close
- SHARE
-
- Close
- Abciximab (ReoPro)-Induced Thrombocytopenia Diagnosed Through Measurement of Heparin-Dependent Antibody
-
Oh YJ, Park TH, Choi YJ, Cho SH, Choi JH, Lee DH, Park SY, Cha KS, Kim MH, Kim YD
- KMID: 2297953
- Korean Circ J.
- 2009 Feb;39(2):75-78.
- doi: 10.4070/kcj.2009.39.2.75
Abciximab (ReoPro) is an extremely potent inhibitor of the glycoprotein IIb/IIIa receptor. Its main application is in the maintenance of coronary flow after suboptimal coronary intervention. Complications associated with this... -
- CITED
-
- Close
- SHARE
-
- Close
- Anterior Mediastinal Hematoma after Cardiopulmonary Resuscitation
-
Kang DG, Kim SE, Hong JY, Park MS, Sim JS, Oh KJ, Kim EJ, Yang BK, Cho GC
- KMID: 2333210
- J Korean Soc Emerg Med.
- 2012 Oct;23(5):730-733.
Anterior mediastinal hematoma is often reported as a complication of cardiopulmonary resuscitation (CPR). CPR can be performed as a result of myocardial infarction, and early percutaneous coronary intervention (PCI) and... -
- CITED
-
- Close
- SHARE
-
- Close
- Acute cerebral infarction due to thrombus formation during GDC embolization for the treatment of intracranial aneurysm: A case report
-
Han SJ, Lee JH, Jang IS, Kim HT, Kwon YE
- KMID: 2299215
- Korean J Anesthesiol.
- 2008 Aug;55(2):254-258.
- doi: 10.4097/kjae.2008.55.2.254
Although Guglielmi Detachable Coil (GDC) endovascular treatment of intracranial aneurysms has become an alternative to surgery, the main complication continues to be thromboembolic events. In our patient, we found thrombus... -
- CITED
-
- Close
- SHARE
-
- Close
- Patients with Arthritis Undergoing Surgery: How Should We Manage Tumour Necrosis Factor Blocking Agents Perioperatively?: A Systematic Literature Review
-
Pieringer , Danninger , Tzaribachev N, Bohler N, Pohanka E, Herold M
- KMID: 1776947
- Yonsei Med J.
- 2013 Jan;54(1):253-257.
- doi: 10.3349/ymj.2013.54.1.253
We systematically reviewed the literature on the infectious risk in patients treated with tumour necrosis factor blocking agents (TNF-BA) undergoing surgery: we searched the Medline (PubMed) and the online archive... -
- CITED
-
- Close
- SHARE
-
- Close
- Urgent Recanalization with Stenting for Severe Intracranial Atherosclerosis after Transient Ischemic Attack or Minor Stroke
-
Park TS, Choi BJ, Lee TH, Song JS, Lee DY, Sung SM
- KMID: 2190392
- J Korean Neurosurg Soc.
- 2011 Oct;50(4):322-326.
- doi: 10.3340/jkns.2011.50.4.322
OBJECTIVE: Stenting of symptomatic intracranial stenosis has recently become an alternative treatment modality. However, urgent intracranial stenting in patients with intracranial stenosis following a transient ischemic attack (TIA) or minor... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Abciximab on the Levels of Circulating Microparticles in Patients with Acute Myocardial Infarction Treated by Primary Angioplasty
-
Cha JJ, Kim JY, Choi EY, Min PK, Cho M, Lee DL, Hong SY, Yoon YW, Lee BK, Hong BK, Rim SJ, Kwon HM
- KMID: 2224815
- Korean Circ J.
- 2013 Sep;43(9):600-606.
- doi: 10.4070/kcj.2013.43.9.600
BACKGROUND AND OBJECTIVES: We investigated the effect of the additional use of abciximab during percutaneous coronary intervention (PCI) on the level of procoagulant microparticles (MPs) in patients with ST-segment elevation... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Combination Treatment with Intracoronary Abciximab and Aspiration Thrombectomy on Myocardial Perfusion in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Stenting
-
Ahn SG, Lee SH, Lee JH, Lee JW, Youn YJ, Ahn MS, Kim JY, Yoo BS, Yoon J, Choe KH, Tahk SJ
- KMID: 2068669
- Yonsei Med J.
- 2014 May;55(3):606-616.
- doi: 10.3349/ymj.2014.55.3.606
PURPOSE: We aimed to investigate whether combination therapy using intracoronary (IC) abciximab and aspiration thrombectomy (AT) enhances myocardial perfusion compared to each treatment alone in patients with ST-elevation myocardial infarction... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of a Dual Drug-Coated Stent With Abciximab and Alpha-Lipoic Acid in a Porcine Coronary Restenosis Model
-
Lim KS, Hong YJ, Hachinohe , Ahmed K, Jeong MH, Kim JH, Sim DS, Lee MG, Park KH, Kim JH, Ahn Y, Cho JG, Park JC, Song SJ, Jung KW, Cho DL, Kang JC
- KMID: 2297930
- Korean Circ J.
- 2011 May;41(5):241-247.
- doi: 10.4070/kcj.2011.41.5.241
BACKGROUND AND OBJECTIVES: The aim of this study was to examine the anti-proliferative and anti-inflammatory effects of a stent coated with abciximab and alpha-lipoic acid (ALA) in a porcine coronary... -
- CITED
-
- Close
- SHARE
-
- Close
- Hemorrhagic pericarditis with cardiac tamponade after percutaneous coronary intervention associated with the use of abciximab
-
Moon SJ, Yoon HJ, Her SH, Lee JM, An HJ, Lee YJ, Jin SW
- KMID: 759974
- Korean J Intern Med.
- 2008 Sep;23(3):156-160.
- doi: 10.3904/kjim.2008.23.3.156
Glycoprotein (GP) IIb/IIIa inhibitors, such as abciximab, are used as adjunctive therapy for percutaneous coronary intervention (PCI) in high-risk non-ST-elevation myocardial infarction (NSTEMI) and in ST-elevation myocardial infarction (STEMI), although... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-inflammatory Effect of Abciximab-Coated Stent in a Porcine Coronary Restenosis Model
-
Hong YJ, Jeong MH, Lee SR, Hong SN, Kim KH, Park HW, Kim JH, Kim W, Ahn Y, Cho JG, Park JC, Kang JC
- KMID: 1713284
- J Korean Med Sci.
- 2007 Oct;22(5):802-809.
- doi: 10.3346/jkms.2007.22.5.802
The aim of this study was to examine the anti-inflammatory effect of abciximab-coated stent in a porcine coronary overstretch restenosis model. Ten abciximab-coated stents, ten sirolimus-eluting stents (SES), and ten... -
- CITED
-
- Close
- SHARE
-
- Close
- A Multicenter, Randomized, Open-Label, Therapeutic, and Exploratory Trial to Evaluate the Tolerability and Efficacy of Platelet Glycoprotein IIb/IIIa Receptor Blocker (Clotinab(TM)) in High-Risk Patients with Percutaneous Coronary Intervention
-
Moon JY, Kim W, Kim JH, Ahn Y, Jeong MH, Kim YH, Hong MK, Park SW, Park SJ, Park S, Ko YG, Choi D, Jang Y
- KMID: 724253
- Yonsei Med J.
- 2008 Jun;49(3):389-399.
- doi: 10.3349/ymj.2008.49.3.389
PURPOSE: This study was designed as a multicenter, randomized, open-label study to evaluate the efficacy and tolerability of Clotinab(TM). We expected to obtain same results as with ReoPro(R) in improving... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Femoral Vascular Closure Devices in Patients Treated with Anticoagulant, Abciximab or Thrombolytics during Percutaneous Endovascular Procedures
-
Kim HY, Choo SW, Roh HG, Han H, Kim SS, Lee JY, Park YR, Lee SH, Shin SW, Park KB, Do YS, Cho SK, Lee IH, Kim SM, Byun HS, Jeon P
- KMID: 753914
- Korean J Radiol.
- 2006 Mar;7(1):35-40.
- doi: 10.3348/kjr.2006.7.1.35
OBJECTIVE: This study assessed the outcomes of using vascular closure devices following percutaneous transfemoral endovascular procedures in the patients who were treated with heparin, abciximab or thrombolytics (urokinase or t-PA)... -
- CITED
-
- Close
- SHARE
-
- Close
